|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Isosorbide mononitrate#Adult Indications and Dosage]] |
| {{Isosorbide mononitrate
| |
| }}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| Isosorbide mononitrate extended-release tablets are indicated for the prevention of [[angina pectoris]] due to [[coronary artery disease]]. The onset of action of oral ISMN is not sufficiently rapid for this product to be useful in aborting an acute angina episode. | |
| | |
| | |
| <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISOSORBIDE MONONITRATE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=897a0327-25d4-4769-bd6a-0e674264017f | publisher = | date = | accessdate = 30 January 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |